164 related articles for article (PubMed ID: 23045286)
1. Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.
Shum CK; Lau ST; Tsoi LL; Chan LK; Yam JW; Ohira M; Nakagawara A; Tam PK; Ngan ES
Oncogene; 2013 Aug; 32(35):4086-99. PubMed ID: 23045286
[TBL] [Abstract][Full Text] [Related]
2. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
[TBL] [Abstract][Full Text] [Related]
3. Conditional deletion of Krüppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury.
Yoshida T; Kaestner KH; Owens GK
Circ Res; 2008 Jun; 102(12):1548-57. PubMed ID: 18483411
[TBL] [Abstract][Full Text] [Related]
4. Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling.
Kramer M; Ribeiro D; Arsenian-Henriksson M; Deller T; Rohrer H
J Neurosci; 2016 Oct; 36(40):10425-10439. PubMed ID: 27707976
[TBL] [Abstract][Full Text] [Related]
5. Involvement of KLF4 in sulforaphane- and iberin-mediated induction of p21(waf1/cip1).
Traka MH; Chambers KF; Lund EK; Goodlad RA; Johnson IT; Mithen RF
Nutr Cancer; 2009; 61(1):137-45. PubMed ID: 19116884
[TBL] [Abstract][Full Text] [Related]
6. Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1Bbeta and TSLC1 in neuroblastoma.
Ochiai H; Takenobu H; Nakagawa A; Yamaguchi Y; Kimura M; Ohira M; Okimoto Y; Fujimura Y; Koseki H; Kohno Y; Nakagawara A; Kamijo T
Oncogene; 2010 May; 29(18):2681-90. PubMed ID: 20190806
[TBL] [Abstract][Full Text] [Related]
7. The role of KLF4 in UVB-induced murine skin tumor development and its correlation with cyclin D1, p53, and p21(Waf1/Cip1) in epithelial tumors of the human skin.
Choi WJ; Youn SH; Back JH; Park S; Park EJ; Kim KJ; Park HR; Kim AL; Kim KH
Arch Dermatol Res; 2011 Apr; 303(3):191-200. PubMed ID: 21132436
[TBL] [Abstract][Full Text] [Related]
8. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.
Liu Z; Yang X; Li Z; McMahon C; Sizer C; Barenboim-Stapleton L; Bliskovsky V; Mock B; Ried T; London WB; Maris J; Khan J; Thiele CJ
Cell Death Differ; 2011 Jul; 18(7):1174-83. PubMed ID: 21252912
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors.
Schwermer M; Lee S; Köster J; van Maerken T; Stephan H; Eggert A; Morik K; Schulte JH; Schramm A
Oncotarget; 2015 Jun; 6(17):15425-35. PubMed ID: 26029996
[TBL] [Abstract][Full Text] [Related]
10. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
[TBL] [Abstract][Full Text] [Related]
11. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
12. Expression of NLRR3 orphan receptor gene is negatively regulated by MYCN and Miz-1, and its downregulation is associated with unfavorable outcome in neuroblastoma.
Akter J; Takatori A; Hossain MS; Ozaki T; Nakazawa A; Ohira M; Suenaga Y; Nakagawara A
Clin Cancer Res; 2011 Nov; 17(21):6681-92. PubMed ID: 21908575
[TBL] [Abstract][Full Text] [Related]
13. Transcription factor Klf4, induced in the lung by oxygen at birth, regulates perinatal fibroblast and myofibroblast differentiation.
Jean JC; George E; Kaestner KH; Brown LA; Spira A; Joyce-Brady M
PLoS One; 2013; 8(1):e54806. PubMed ID: 23372771
[TBL] [Abstract][Full Text] [Related]
14. Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1-mediated p53/KLF4 complex stabilization.
Xi G; Shen X; Wai C; White MF; Clemmons DR
J Biol Chem; 2019 Feb; 294(7):2407-2421. PubMed ID: 30578299
[TBL] [Abstract][Full Text] [Related]
15. KLF4 Regulates Corneal Epithelial Cell Cycle Progression by Suppressing Canonical TGF-β Signaling and Upregulating CDK Inhibitors P16 and P27.
Tiwari A; Swamynathan S; Alexander N; Gnalian J; Tian S; Kinchington PR; Swamynathan SK
Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):731-740. PubMed ID: 30786277
[TBL] [Abstract][Full Text] [Related]
16. MYCN-mediated overexpression of mitotic spindle regulatory genes and loss of p53-p21 function jointly support the survival of tetraploid neuroblastoma cells.
Gogolin S; Batra R; Harder N; Ehemann V; Paffhausen T; Diessl N; Sagulenko V; Benner A; Gade S; Nolte I; Rohr K; König R; Westermann F
Cancer Lett; 2013 Apr; 331(1):35-45. PubMed ID: 23186832
[TBL] [Abstract][Full Text] [Related]
17. The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter.
Zhang W; Geiman DE; Shields JM; Dang DT; Mahatan CS; Kaestner KH; Biggs JR; Kraft AS; Yang VW
J Biol Chem; 2000 Jun; 275(24):18391-8. PubMed ID: 10749849
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
[TBL] [Abstract][Full Text] [Related]
19. Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma.
Liontas A; Yeger H
Anticancer Res; 2004; 24(2B):987-98. PubMed ID: 15161054
[TBL] [Abstract][Full Text] [Related]
20. WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.
Masserot C; Liu Q; Nguyen E; Gattolliat CH; Valteau-Couanet D; Bénard J; Huber C; Ségal-Bendirdjian E
Mol Oncol; 2016 Feb; 10(2):240-52. PubMed ID: 26482175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]